Anal Cancer

Cancer made me more empathetic, as well as an advocate for the HPV vaccine.

After I was diagnosed with anal cancer, doctors wanted me to get an colostomy bag, but I refused. Later on, I had to voice my concern about a drug that could improve my chances for survival.

The priority review will focus on retifanlimab for the treatment of certain adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal who did not tolerate platinum-based chemotherapy. Currently, according to Incyte, there are no approved treatments for this patient population.

To halt the rise of anal cancer, everyone eligible needs to be vaccinated against HPV, which causes most cases of the disease.

Sexual and gender minorities are not receiving the same standard of clinical care as other patients with cancer.

HPV and Anal cancer are associated with one another, here's what you need to know.

From today’s top entertainers to racial disparities in access to pain treatment, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.

Research continues to drive the oncology field.

A recent study found that socioeconomic status can play a role in survival for patients with anal cancer.

Treatment of HIV has drastically improved since the 1980s, but many of these individuals are still facing barriers to proper cancer care.

More personalized approaches are being developed to treat patients with metastatic disease.

Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.

The PD-1 inhibitor, Opdivo, may be a promising option for patients with advanced anal cancer, according to a recent study.

From stigma to convenience, there are many reasons why people do not get the HPV vaccine, although it can prevent some types of cancer. Lois Ramondetta, M.D., discusses updated recommendations and hopes for getting more young people vaccinated.

Opdivo may be a promising treatment option for patients with squamous cell carcinoma of the anal canal.

A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.

States with the highest incidence of, and mortality from, cervical cancer also have the lowest uptake of the human papillomavirus (HPV) vaccine by adolescent girls, researchers found in a recent study.

NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.

Cases of HPV-related cancers are on the rise, specifically those associated with head and neck and anal cancers.

In the right cancer, radiation and chemotherapy can make a powerful duo.

The latest in cancer prevention, diagnosis and treatment.

What is multidisciplinary care, and where can patients get it?